Home Search
Public Safety - search results
If you're not happy with the results, please do another search
How global evidence can improve outcomes for spinal patients
Everard Munting, President of EUROSPINE, explains why sharing knowledge about spinal treatments on a global scale is the most effective way to develop best practice and enable early interventions.
Benchmarking Regulatory systems governing veterinary medicines
Rick Clayton, Technical Director, AnimalhealthEurope, unpacks Benchmarking Regulatory systems governing veterinary medicines in this the first of a series of three articles.
Italian approach to COVID-19: Dental industry perspective
Dr Ferruccio Berto, National Vice President and NLO for Foreign Affairs of the National Association of Italian Dentists, provides a dental industry perspective on the Italian approach to the COVID-19 pandemic.
International Women’s Day: Tech experts discuss tackling gender biases
In recognition of International Women's Day, a range of influential experts in the technology sector discuss tackling gender biases in the industry.
Social housing: Why risk focus is key to delivery
Following publication of the Social Housing and Planning White Papers, Mark Alcock, principal risk manager at, Equib, offers Registered Providers his expert advise as they plan for a post-pandemic future.
COVID vaccines for mutations will be given faster approval in the UK
Medical regulators will fast-track COVID vaccines for mutations, similar to how seasonal flu shots are developed and released.
The impact of digital care platforms on healthcare professionals and patients
Dr Simon Bourne, founder and CEO of my mhealth and former COPD lead at Southampton University, examines the digital goals outlined in the NHS long-term plan and the impact of digital patient care platforms on healthcare professionals (HCPs) and patients.
Tackling vaccination misinformation with local government communications
Karen Steel at Granicus discusses how local government communications could significantly help to stop the spread of COVID misinformation, especially when it comes to vaccinations.
FDA approves the Johnson & Johnson vaccine for use
The US Food and Drug Administration (FDA) approved the Johnson & Johnson vaccine, with an efficacy of 86%, as the next to be rolled out across the US.
The UK’s legalisation of medicinal cannabis
David Hardstaff of BCL’s Cannabis Law & Regulatory team considers the success of the UK’s legalisation of medicinal cannabis products.
Sustainable communities, ecosystem services and human well‐being
Michael Slimak Ph.D., retired National Program Director for the Sustainable & Healthy Communities Research Program at the U.S. Environmental Protection Agency (EPA), explores the most pressing challenges today that reflect the need to understand interdependencies between the natural and social sciences.
How to support employee wellbeing within local authorities
Grainne Elliott, CMO of Thrive, describes four things that employees of local authorities need to support their wellbeing both on and off the job and can be delivered via this new emphasis on digital tools.
Targeted policy support for emerging biomedical innovations
Michael Morrison, Senior Researcher in Social Science at the University of Oxford, illustrates the importance of emerging biomedical innovations in the UK.
Accelerating innovation: Lead batteries look to the future
Dr Alistair Davidson, Director, Consortium for Battery Innovation, describes accelerating innovation when it comes to the use of lead batteries in the future.
A national strategy for social care could save the NHS £1 billion every year
Research found that the supported housing and integrated mental health system could save the NHS £950 million if used as a national strategy for social care.
EU allocates additional €500 million to COVAX facility
The European Union has allocated an additional €500 million to the COVAX facility, bringing its total contribution to €1 billion.
Science needs to overcome “structural racism” to end the HIV epidemic
A new report published in The Lancet investigates why 43% of HIV deaths in 2018 happened in the Black community, with policy solutions for the ongoing HIV epidemic.
How governments can build on the use of data and tech in fighting COVID-19
George Atalla, EY Global Government & Infrastructure Leader, explores the effect that COVID-19 has had on the use of data and technology in healthcare.
New white paper will give Government more control over NHS
The legislative changes in the white paper released today (11 February) include giving local and central Government more control over the NHS - which is expected to be implemented in 2022.
Overcoming the challenges of recruitment in the age of COVID-19
Rachel Robinson, EVP Public Sector Services at Teleperformance, comments on how businesses can successfully recruit, onboard and train new starters all while working remotely.